Greater Manchester Medicines Management Group

images courtesy of NHS Photo Library

NHS logo

Recommendations

On this page you will find all our current recommendations, initially sorted by published date. The ‘Recommendations’ and ‘Published’ column headings are active links that will sort the information in ascending or descending order. Please note that all our recommendations are valid unless they are superseded by NICE or national guidance.

If you are a healthcare professional working with the GM region and would like to submit information for a recommendation to be reviewed then please contact the professional secretary to the group.

To view our recommendations sorted by BNF chapter or to view those superseded by NICE or national guidance click the links to the left.

Please note that the new drug recommendations no longer contain a review date as they will be reviewed as and when substantial new evidence that may change the original recommendation becomes available. This will be highlighted through regular horizon scanning activities. All previous review dates on old recommendations are invalid as they will also be reviewed as outlined. In addition if a NICE TA is published then the new drug recommendation will be superseded by the NICE TA – these recommendations will be moved to the archive recommendation section of the website within 90 days of the NICE TA being issued.

display

22 recommendations currently listed 

spacer 

spacer 

spacer 

spacer 

spacer 

 

spacer

RecommendationsA-Z asc 

Published 

Status 

 

pdf document (94 KB)  

Bevacizumab in AMD updated  

Nov 2015 

 

 

pdf document (125 KB)  

Bezlotoxumab for the prevention of recurrence of Clostridium difficile infection in adults at high risk of recurrence.  

Oct 2019 

Final 

 

pdf document (648 KB)  

Blood Glucose Testing Strips Evaluation  

Dec 2017 

Review postponed indefinitely 

 

pdf document (177 KB)  

Colchicine for the treatment of pericarditis pain (Unlicensed indication)  

Jul 2016 

Final 

 

pdf document (353 KB)  

Dibotermin alfa (InductOs®) for the treatment of non-union fracture  

Sep 2019 

Final 

  new  
27 Jan 20  

pdf document (171 KB)  

Escalated dosing of ustekinumab for Crohn’s disease  

Jan 2020 

Final 

 

pdf document (71 KB)  

Fidaxomicin (Dificlir®) for the Treatment of Clostridium Difficile Infection  

Oct 2019 

Final 

 

pdf document (218 KB)  

FreeStyle Libre® Flash Glucose Monitoring System.  

Jul 2019 

Final 

 

pdf document (32 KB)  

GMMMG Vitamin D statement  

Sep 2016 

 

 

pdf document (113 KB)  

Insulin Degludec for Type 1 and 2 DM (updated)  

Jun 2014 

Final 

 

pdf document (85 KB)  

Levonorgestrel-containing intrauterine systems  

Sep 2019 

Final 

 

pdf document (140 KB)  

Melatonin for primary insomnia (adults)  

Sep 2008 

Final 

 

pdf document (112 KB)  

Metoject (methotrexate) Injection for RA  

Oct 2008 

Final 

 

pdf document (143 KB)  

Octreotide for treatment of certain gastrointestinal indications  

May 2018 

 

 

pdf document (137 KB)  

PICO® dressings for difficult to manage wounds  

May 2015 

Final 

 

pdf document (102 KB)  

Probiotics (updated)  

Apr 2013 

 

 

pdf document (346 KB)  

Rituximab for Treatment of Refractory Primary Idiopathic Immune Cytopenias  

May 2018 

 

 

pdf document (215 KB)  

Toujeo® Insulin Glargine  

May 2019 

Final 

 

pdf document (197 KB)  

Umeclidinium/Vilanterol (Anoro® Ellipta®) Combination Inhaler for COPD  

Sep 2014 

Final 

 

pdf document (230 KB)  

Vit D for Insufficiency & Deficiency  

Mar 2016 

Final 

 

pdf document (241 KB)  

Vitamin D For Deficiency and Insufficiency (paediatrics)  

Apr 2016 

Final 

 

pdf document (170 KB)  

Xultophy® (Liraglutide +Insulin Degludec) for the treatment of adults with T2DM  

May 2015 

Final 

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer